BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3699217)

  • 1. Lack of skeletal radiographic changes during short-term etretinate therapy for psoriasis.
    Gilbert M; Ellis CN; Voorhees JJ
    Dermatologica; 1986; 172(3):160-3. PubMed ID: 3699217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Skeletal alterations associated with long-term etretinate therapy].
    Okada N; Higashiyama M; Morimoto S; Yoshikawa K
    Nihon Hifuka Gakkai Zasshi; 1991 Apr; 101(5):547-52. PubMed ID: 1890751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone changes in children on long-term treatment with etretinate.
    Halkier-Sørensen L; Laurberg G; Andresen J
    J Am Acad Dermatol; 1987 May; 16(5 Pt 1):999-1006. PubMed ID: 3584585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective radiographic study of skeletal changes after long-term etretinate therapy.
    Melnik B; Glück S; Jungblut RM; Goerz G
    Br J Dermatol; 1987 Feb; 116(2):207-12. PubMed ID: 3828215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extraspinal tendon and ligament calcification associated with long-term therapy with etretinate.
    DiGiovanna JJ; Helfgott RK; Gerber LH; Peck GL
    N Engl J Med; 1986 Nov; 315(19):1177-82. PubMed ID: 3463863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone changes and their significance in children with ichthyosis on long-term etretinate therapy.
    Paige DG; Judge MR; Shaw DG; Atherton DJ; Harper JI
    Br J Dermatol; 1992 Oct; 127(4):387-91. PubMed ID: 1419759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study of bone changes in adults treated with etretinate.
    Halkier-Sørensen L; Andresen J
    J Am Acad Dermatol; 1989 Jan; 20(1):83-7. PubMed ID: 2913084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal hyperostosis and extraosseous calcification in patients receiving long-term etretinate (Tigason).
    Wilson DJ; Kay V; Charig M; Hughes DG; Creasy TS
    Br J Dermatol; 1988 Nov; 119(5):597-607. PubMed ID: 3207613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of hepatitis related to etretinate therapy and hepatitis B vaccine.
    Green C; Lakshmipathi T
    Dermatologica; 1991; 182(2):119-20. PubMed ID: 1828773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of significant skeletal changes after long-term, low-dose retinoid therapy: case report and review of the literature.
    Halverstam CP; Zeichner J; Lebwohl M
    J Cutan Med Surg; 2006; 10(6):291-9. PubMed ID: 17241599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone-scintigraphic examinations in patients treated with retinoids: a prospective study.
    Török L; Galuska L; Kása M; Kádár L
    Br J Dermatol; 1989 Jan; 120(1):31-6. PubMed ID: 2534736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint pains with psoriasis and long-term systemic etretinate therapy: a case report and summary of 12 cases.
    Ishida Y; Ozawa A; Ohkido M; Imai N
    J Dermatol; 1993 Oct; 20(10):651-3. PubMed ID: 8277044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral density of the lumbar spine in psoriatic patients with long term etretinate therapy.
    Okada N; Nomura M; Morimoto S; Ogihara T; Yoshikawa K
    J Dermatol; 1994 May; 21(5):308-11. PubMed ID: 8051315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
    Mahrle G; Schulze HJ; Färber L; Weidinger G; Steigleder GK
    J Am Acad Dermatol; 1995 Jan; 32(1):78-88. PubMed ID: 7822521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etretinate therapy causes increases in lipid levels in patients with psoriasis.
    Ellis CN; Swanson NA; Grekin RC; Goldstein NG; Bassett DR; Anderson TF; Voorhees JJ
    Arch Dermatol; 1982 Aug; 118(8):559-62. PubMed ID: 7103524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety of etretinate as long-term therapy for psoriasis: results of the etretinate follow-up study.
    Stern RS; Fitzgerald E; Ellis CN; Lowe N; Goldfarb MT; Baughman RD
    J Am Acad Dermatol; 1995 Jul; 33(1):44-52. PubMed ID: 7601945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of psoriasis vulgaris whose lipoprotein lipase activity decreased during treatment with etretinate].
    Seishima M; Mori S; Seishima M; Noma A
    Nihon Hifuka Gakkai Zasshi; 1989 May; 99(6):731-4. PubMed ID: 2585775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance for skeletal toxicity of children treated with etretinate.
    Glover MT; Peters AM; Atherton DJ
    Br J Dermatol; 1987 May; 116(5):609-14. PubMed ID: 3297126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report: psoriatic erythroderma with bilateral osseous bridge across the acetabulum.
    Tsuji S; Tomita T; Inaoka M; Higashiyama M
    Clin Orthop Relat Res; 2010 Apr; 468(4):1173-7. PubMed ID: 19657703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Etretinate (Tigason) and bone changes].
    Halkier-Sørensen L; Andresen JH
    Ugeskr Laeger; 1988 Jul; 150(27):1674-6. PubMed ID: 3291352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.